Keros Therapeutics, Inc.
← Back to KROS Overview

Keros Therapeutics, Inc. (KROS)

Revenue & Top-Line Growth

Latest Revenue

$367K

Financial Fundamentals

KROSQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B-4.7%-99.8%0.03B-84.5%
2025-12-310.00B-97.3%-87.3%0.24B+6775.0%
2025-09-300.01B-21.5%+3575.8%0.25B+37798.3%
2025-06-300.02B-91.4%+49002.7%0.23B+85820.3%
2025-03-310.21B+6844.3%+254413.3%0.21B+91657.7%
2024-12-310.00B+684.0%+2027.3%0.00B+2251.0%
2024-09-300.00B+948.6%+4750.0%0.00B+8037.5%
2024-06-300.00B-55.4%0.00B
2024-03-310.00B-42.0%0.00B
2023-12-310.00B+1687.5%0.00B
2023-09-300.00B0.00B-100.0%
2023-06-300.00B0.00B
2023-03-310.00B0.00B
2022-12-310.00B0.00B
2022-09-300.00B0.02B+19900.0%
2022-06-300.00B0.02B+19900.0%
2022-03-310.00B0.02B
2021-12-310.02B0.02B
2021-09-300.00B0.00B-96.0%
2021-06-300.00B0.00B-98.0%
2021-03-310.00B0.00B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.01B
2020-03-310.00B0.01B
2019-12-310.00B0.0%0.01B
2019-09-300.00B0.0%0.00B
2019-06-300.00B0.0%0.00B
2019-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.24B+6775.0%
20240.00B+2251.0%
20230.00B
20220.00B
20210.02B
20200.00B
20190.01B
20180.01B